We are specialists in monitoring the brain using ultrasound. With the Acoustocerebrography (ACG) we have developed, we are the only company in the world who can non-invasively detect the smallest changes in the cellular and molecular structure of the brain acutely or in permanent monitoring. So far, we have been able to detect invisible processes in the brain earlier than with traditional methods. Additionally, through a permanent observation of the processes in the brain tissue, the ACG allows the detection of critical gradients during their procedure. For the first time, leading indicators can be defined for a range of pathological findings, about which even specialists have hitherto been in the dark. For example, our technology-based clinical trials show that ACG is suitable for identifying and classifying a stroke and pre-qualifying White Matter Lesions (WML).